Literature DB >> 6704582

Role of auto-inhibitory feed-back in cardiac sympathetic transmission assessed by simultaneous measurements of changes in 3H-efflux and atrial rate in guinea-pig atrium.

J A Angus, A Bobik, G P Jackman, I J Kopin, P I Korner.   

Abstract

Guinea-pig right atria were labelled with [3H]-noradrenaline or [3H]-dopamine before superfusion in a flow-cell. Choice of label did not significantly alter either the relationship between 3H-efflux and number of electrical field pulses or the inhomogeneity of labelling. The relationship between 3H-efflux and frequency of 4 field pulses (0.125-2 Hz) was hyperbolic and similar to the tachycardia-frequency relationship measured simultaneously. No evidence was found for a U shaped 3H-efflux-frequency relationship (Story, McCulloch, Rand & Standford-Starr, 1981). Phentolamine (1 microM) did not alter the 3H-efflux or atrial rate responses to 4 field pulses at stimulus levels that gave 50-60% of the maximum rate response. In the presence of neuronal uptake inhibition (desipramine, DMI 0.1 microM), rate and 3H-efflux responses to 4 field pulses were enhanced at all frequencies and were further increased by phentolamine. In the absence of DMI, prolonged trains of field pulses (8 and 12 pulses) at low frequency (0.25 Hz) were not sufficient to activate auto-inhibitory feed-back. At 2 Hz phentolamine enhanced both 3H-efflux and rate responses at 12 field pulses. We conclude that in guinea-pig right atrium auto-inhibitory feed-back plays little role in the modulation of transmitter release at levels of stimulation that cause 50-60% of maximum tissue response. This is because neuronal uptake normally prevents synaptic concentrations of noradrenaline from activating prejunctional alpha 2-adrenoceptors. Stimulation sufficient to induce a near-maximal response or the presence of neuronal uptake inhibition are necessary to evoke autoinhibitory feed-back.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704582      PMCID: PMC1986966          DOI: 10.1111/j.1476-5381.1984.tb10762.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

2.  Physiological significance of alpha-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation.

Authors:  S Z Langer; E Adler-Graschinsky; O Giorgi
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

3.  Partial agonist of clonidine on prejunctional and postjunctional alpha-adrenoceptors.

Authors:  I C Medgett; M W McCulloch; M J Rand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

4.  3 H-noradrenaline release and mechanical response in the field stimulated mouse vas deferens.

Authors:  L O Farnebo; T Malamfors
Journal:  Acta Physiol Scand Suppl       Date:  1971

5.  Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation.

Authors:  I J Kopin; G R Breese; K R Krauss; V K Weise
Journal:  J Pharmacol Exp Ther       Date:  1968-06       Impact factor: 4.030

6.  Electrical field-stimulated release of norepinephrine-H3 from rat atrium: effects of ions and drugs.

Authors:  R I Katz; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1969-10       Impact factor: 4.030

7.  The effect of drugs on the release of norepinephrine-H from central nervous system tissued by electrical stimulation in vitro.

Authors:  R J Baldessarini; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1967-04       Impact factor: 4.030

8.  Prejunctional effects of a purified toxin from the scorpion Tityus serrulatus: release of 3H-noradrenaline and enhancement of transmitter overflow elicited by nerve stimulation.

Authors:  S Z Langer; E Adler-Graschinsky; A P Almeida; C R Diniz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Modulation of sympathetic transmission by neuronally-released dopamine.

Authors:  W Hope; H Majewski; M W McCulloch; M J Rand; D F Story
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

10.  The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat.

Authors:  S Z Langer
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

View more
  6 in total

1.  Cholinesterase activity and exposure time to acetylcholine as factors influencing the muscarinic inhibition of [3H]-noradrenaline overflow from guinea-pig isolated atria.

Authors:  H Fuder; E Muscholl; K Wolf
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

2.  Transmitter release modulated by alpha-adrenoceptor antagonists in the rabbit mesenteric artery: a comparison between noradrenaline outflow and electrical activity.

Authors:  S Mishima; H Miyahara; H Suzuki
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

3.  Influence of phorbol esters on stimulation-induced noradrenaline release and contractile force of isolated guinea-pig atria.

Authors:  H Brasch
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

4.  Field stimulation-induced noradrenaline release from guinea-pig atria is modulated by prejunctional alpha 2-adrenoceptors and protein kinase C.

Authors:  H Brasch
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

5.  Alpha-adrenoceptor antagonists and the release of noradrenaline in rabbit cerebral cortex slices: support for the alpha-autoreceptor hypothesis.

Authors:  P Heepe; K Starke
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

6.  On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.

Authors:  H Fuder; M Buder; H D Riers; G Rothacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.